Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300908 · ClinicalTrials.gov registry record · NA
Contextualizing & Responding to HIV Risk Behaviors
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03300908 is a NA study that has completed, run by Columbia University. The registered enrollment target is 32 participants.
The verdict
NCT03300908, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study was to pilot test the potential for improvement in antiretroviral medication adherence of a an adapted group-based, multi-session, community-based Antiretroviral Therapy (ART) adherence and risk reduction intervention, Project ADHerence Education and Risk Evaluation (ADHERE). Project ADHERE was compared to a single-session group-based medication adherence intervention, Medication Adherence and Care Engagement (MACE). A secondary aim was to examine the impact of Project ADHERE on HIV risk behaviors (i.e., illicit drug use and unprotected sexual behavior). This study was designed to inform, design, and pilot test the two antiretroviral medication adherence interventions for HIV-infected formerly incarcerated individuals.
Interventions
- BEHAVIORAL Project ADHERE
- BEHAVIORAL MACE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-07-05 |
| Est. Completion | 2016-12-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03300908
The ClinicalTrials.gov registry entry for NCT03300908 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Project ADHERE is the first listed.
NCT03300908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03300908 about?
NCT03300908 is a clinical study titled "Contextualizing & Responding to HIV Risk Behaviors". The purpose of this study was to pilot test the potential for improvement in antiretroviral medication adherence of a an adapted group-based, multi-session, community-based Antiretroviral Therapy (ART) adherence and risk reduction intervention, Project ADHerence Education and Risk Evaluation (ADHERE...
What is the current status of trial NCT03300908?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-07-05. Estimated completion is 2016-12-21.
What interventions are being tested in trial NCT03300908?
The interventions under investigation include: Project ADHERE (BEHAVIORAL), MACE (BEHAVIORAL).
Who is sponsoring clinical trial NCT03300908?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.